John F Benedik insider trades: Cortex Pharmaceuticals Inc/De/ (COR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 13, 2009 | COR | ↑ Buy | 18,000 | $0.59 | $11K | Direct | Jan 13, 2009 (0d) |
| Mar 28, 2008 | COR | ↑ Buy | 12,000 | $0.77 | $9K | Direct | Mar 31, 2008 (3d) |
| Aug 21, 2006 | ARXX | ↑ Buy | 1,000 | $9.75 | $10K | Direct | Aug 22, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other COR insiders
Open-market trades in the last 12 months
About John F Benedik's insider trades
John F Benedik is a director at Cortex Pharmaceuticals Inc/De/ (COR). Since Aug 21, 2006, John has reported 3 open-market purchases worth $30K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every COR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.